
BioThrust builds bionic bioreactors that enable controllable, scalable production of therapeutic and research cell types with higher yields and gentler cultivation conditions. Their ComfyCell platform uses a proprietary Membrane Stirrer to provide bubble-free gas exchange, reduce shear stress, and increase gas transfer rates; the system incorporates CFD-driven design, mass flow controllers, and a touchscreen interface for process control. The product supports linear scale-up from 100 mL to 200 L and is application-agnostic across iPSCs, NK cells, organoids, cultured meat, and synthetic biologics. BioThrust sells its platform and services to biomanufacturing and cell therapy companies seeking industrial-scale, reproducible cell production.

BioThrust builds bionic bioreactors that enable controllable, scalable production of therapeutic and research cell types with higher yields and gentler cultivation conditions. Their ComfyCell platform uses a proprietary Membrane Stirrer to provide bubble-free gas exchange, reduce shear stress, and increase gas transfer rates; the system incorporates CFD-driven design, mass flow controllers, and a touchscreen interface for process control. The product supports linear scale-up from 100 mL to 200 L and is application-agnostic across iPSCs, NK cells, organoids, cultured meat, and synthetic biologics. BioThrust sells its platform and services to biomanufacturing and cell therapy companies seeking industrial-scale, reproducible cell production.